Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
91
days
TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors
Authors
Hans Gelderblom; Emanuela Palmerini; Michiel van de Sande; Javier Martin-Broto; Gabriel Tinoco; Elyse Seltzer; Madhu Davies; Ruth Coll; Sander Veltkamp; Jean-Yves BlayShow moreShow less
Affiliations
1. Leiden University Medical Center; 2. IRCCS Istituto Ortopedico Rizzoli; 3. Leiden University Medical Centre; 4. Fundación Jimenez Diaz University Hospital; 5. University Hospital General de Villalba; 6. Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD; UAM); 7. The Ohio State University Comprehensive Cancer Center; 8. Clinical Development, SynOx Therapeutics Inc., Philadelphia, PA, USA; 9. Clinical Development, SynOx Therapeutics Ltd., Oxford, UK; 10. Centre Léon BérardShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days